Big DNA wins Life Sciences Award

01 December 2009
Last night, at a ceremony in Edinburgh,
life sciences firm BigDNA, founded at Roslin BioCentre two years ago, won Nexxus'
Most Promising Young Life Science Company of the Year Award (East). From the
H1N1 'swine flu' to the seasonal flu, new viral strains sweep around the globe
each year while scientists and companies race to produce better vaccines. BigDNA's
new vaccine technology is designed to manufacture vaccines faster and more
cheaply than ever before.
Dr. John March, Chief Executive Officer said, "We
have progressed in leaps and bounds in the last two years in terms of technology
development. This award
is fantastic in terms of official recognition of the progress we have made,
and in particular, it identifies the important role that our dedicated and
innovative science team have played in this progression."
The company has enjoyed rapid growth, to twelve employees half
of whom are PhD scientists. It raised additional investment of £1.5million recently,
and former Defence Procurement Minister, Lord Freeman was appointed as
chairman last year. Big DNA announced the establishment of its
Science Advisory panel
last month, which includes distinguished scientist Professor Noreen Murray
among others. The firm's vaccine manufacturing facility was officially
opened by Scottish Finance Minister John Swinney MSP in May of
this year.
Big DNA will begin clinical testing of their lead product, a Hepatitis
B vaccine, in 2011 and then move on to develop additional vaccines, for
influenza,
Herpes
Simplex 2 and other diseases where a high unmet need, or less than ideal
vaccine, currently exists.
Dr. Karen Jervis, Commercial Director said, "The
next few years will be pivotal for BigDNA as we develop our clinical vaccine
portfolio. We will continue
to strengthen and build the company through new appointments and international
partnerships, both in the human and animal health arenas. Every member
of our team is delighted to receive the Nexxus award as it reaffirms their
motivation
in achieving these goals."
www.bigdna.co.uk

